{"database": "lobbying", "table": "lobbying_activities", "rows": [[1874623, "dd92d12b-7c62-47ba-9fcb-34fd266813e1", "Q3", "MR. BRIAN KELLY", 40024191, "INTELLIA THERAPEUTICS", 2016, "third_quarter", "MED", "Gene Editing", "HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),Natl Science Foundation (NSF),SENATE,White House Office", 15000, null, 0, 0, "2016-10-11T10:08:03.150000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1874623"], "units": {}, "query_ms": 0.3174289595335722, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}